Results for tag: "Bronchiolitis Drug"

Bronchiolitis is a common lower respiratory tract infection in infants and young children. It is caused by a virus and is characterized by inflammation of the bronchioles, the smallest airways in the lungs. Treatment for bronchiolitis is mainly supportive, but some drugs may be used to reduce symptoms and improve breathing. Bronchodilators, such as albuterol, are used to open the airways and reduce wheezing. Corticosteroids, such as budesonide, are used to reduce inflammation and mucus production. Antibiotics may be used if a bacterial infection is present. The bronchiolitis drug market is a subset of the larger respiratory drug market. It includes drugs used to treat bronchiolitis, as well as other respiratory conditions such as asthma, COPD, and cystic fibrosis. The market is highly competitive, with many companies offering a variety of products. Some of the major players in the bronchiolitis drug market include GlaxoSmithKline, Merck, AstraZeneca, Novartis, and Boehringer Ingelheim. Show Less Read more